337 related articles for article (PubMed ID: 23308854)
21. Geocoding rural addresses in a community contaminated by PFOA: a comparison of methods.
Vieira VM; Howard GJ; Gallagher LG; Fletcher T
Environ Health; 2010 Apr; 9():18. PubMed ID: 20406495
[TBL] [Abstract][Full Text] [Related]
22. Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.
Kerger BD; Copeland TL; DeCaprio AP
Drug Chem Toxicol; 2011 Oct; 34(4):396-404. PubMed ID: 21770727
[TBL] [Abstract][Full Text] [Related]
23. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant.
Woskie SR; Gore R; Steenland K
Ann Occup Hyg; 2012 Nov; 56(9):1025-37. PubMed ID: 22539556
[TBL] [Abstract][Full Text] [Related]
24. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
25. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
MacNeil J; Steenland NK; Shankar A; Ducatman A
Environ Res; 2009 Nov; 109(8):997-1003. PubMed ID: 19740462
[TBL] [Abstract][Full Text] [Related]
26. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.
Shin HM; Vieira VM; Ryan PB; Steenland K; Bartell SM
Environ Health Perspect; 2011 Dec; 119(12):1760-5. PubMed ID: 21813367
[TBL] [Abstract][Full Text] [Related]
27. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
Melzer D; Rice N; Depledge MH; Henley WE; Galloway TS
Environ Health Perspect; 2010 May; 118(5):686-92. PubMed ID: 20089479
[TBL] [Abstract][Full Text] [Related]
28. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM; Calafat AM; Lyu C; Kato K; Ryan PB; Steenland K
Environ Health Perspect; 2010 Feb; 118(2):222-8. PubMed ID: 20123620
[TBL] [Abstract][Full Text] [Related]
29. Retrospective exposure reconstruction using approximate Bayesian computation: A case study on perfluorooctanoic acid and preeclampsia.
Zhu Y; Shin HM; Jiang L; Bartell SM
Environ Res; 2022 Jun; 209():112892. PubMed ID: 35149111
[TBL] [Abstract][Full Text] [Related]
30. Evidence of Air Dispersion: HFPO-DA and PFOA in Ohio and West Virginia Surface Water and Soil near a Fluoropolymer Production Facility.
Galloway JE; Moreno AVP; Lindstrom AB; Strynar MJ; Newton S; May AA; Weavers LK
Environ Sci Technol; 2020 Jun; 54(12):7175-7184. PubMed ID: 32458687
[TBL] [Abstract][Full Text] [Related]
31. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.
Chang ET; Adami HO; Boffetta P; Cole P; Starr TB; Mandel JS
Crit Rev Toxicol; 2014 May; 44 Suppl 1():1-81. PubMed ID: 24793953
[TBL] [Abstract][Full Text] [Related]
32. Critical review on PFOA, kidney cancer, and testicular cancer.
Bartell SM; Vieira VM
J Air Waste Manag Assoc; 2021 Jun; 71(6):663-679. PubMed ID: 33780327
[TBL] [Abstract][Full Text] [Related]
33. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population.
Avanasi R; Shin HM; Vieira VM; Bartell SM
Environ Res; 2016 Apr; 146():299-307. PubMed ID: 26796985
[TBL] [Abstract][Full Text] [Related]
34. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
Karnes C; Winquist A; Steenland K
Environ Res; 2014 Jan; 128():78-83. PubMed ID: 24299613
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).
Steenland K; Fletcher T; Savitz DA
Environ Health Perspect; 2010 Aug; 118(8):1100-8. PubMed ID: 20423814
[TBL] [Abstract][Full Text] [Related]
36. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water.
Nolan LA; Nolan JM; Shofer FS; Rodway NV; Emmett EA
Reprod Toxicol; 2009 Jun; 27(3-4):231-238. PubMed ID: 19049861
[TBL] [Abstract][Full Text] [Related]
37. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia.
Shin HM; Vieira VM; Ryan PB; Detwiler R; Sanders B; Steenland K; Bartell SM
Environ Sci Technol; 2011 Feb; 45(4):1435-42. PubMed ID: 21226527
[TBL] [Abstract][Full Text] [Related]
38. Perfluorooctanoic Acid (PFOA) Exposure in Early Life Increases Risk of Childhood Adiposity: A Meta-Analysis of Prospective Cohort Studies.
Liu P; Yang F; Wang Y; Yuan Z
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30241417
[TBL] [Abstract][Full Text] [Related]
39. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.
Kudo N; Kawashima Y
J Toxicol Sci; 2003 May; 28(2):49-57. PubMed ID: 12820537
[TBL] [Abstract][Full Text] [Related]
40. Perfluorooctanoic acid and low birth weight: Estimates of US attributable burden and economic costs from 2003 through 2014.
Malits J; Blustein J; Trasande L; Attina TM
Int J Hyg Environ Health; 2018 Mar; 221(2):269-275. PubMed ID: 29175300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
